Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal Buprenorphine-naloxone Effects on Fetus and Infant
NCT03291847Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jun 2018
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine, naloxone in opioid use disorder (OUD), sponsored by Johns Hopkins University. Started Jun 2018; status: completed.
02
Drugs
buprenorphinenaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03291847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291847.